Axonics, Inc. (AXNX) financial statements (2022 and earlier)

Company profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments220,878241,181183,674157,524
Cash and cash equivalents220,878241,181171,08298,306
Short-term investments  12,59259,218
Receivables29,04418,2707,879427
Inventory, net of allowances, customer advances and progress billings64,94663,06015,6593,673
Inventory64,94663,06015,6593,673
Other undisclosed current assets6,4495,4354,4683,716
Total current assets:321,317327,946211,680165,340
Noncurrent Assets
Property, plant and equipment6,9156,3283,0472,784
Intangible assets, net (including goodwill)211,979196311426
Goodwill105,510   
Intangible assets, net (excluding goodwill)106,469196311426
Other noncurrent assets7,7347,7364,7843,356
Total noncurrent assets:226,62814,2608,1426,566
TOTAL ASSETS:547,945342,206219,822171,906
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities25,50223,29211,4315,119
Accounts payable7,65410,6605,8823,436
Accrued liabilities5,4356,6842,1741,683
Employee-related liabilities12,4135,9483,375 
Debt 21,110602 
Other undisclosed current liabilities1,3661,280 768
Total current liabilities:26,86845,68212,0335,887
Noncurrent Liabilities
Long-term debt and lease obligation9,0529,15424,78619,463
Long-term debt, excluding current maturities  20,33619,463
Operating lease, liability9,0529,1544,450
Liabilities, other than long-term debt29,587   
Deferred income tax liabilities19,217  
Other liabilities10,370   
Other undisclosed noncurrent liabilities (9,154) 3,281
Total noncurrent liabilities:38,6399,15424,78622,744
Total liabilities:65,50754,83636,81928,631
Stockholders' equity
Stockholders' equity attributable to parent482,438287,370183,003143,275
Common stock5433
Additional paid in capital803,559522,296363,012243,337
Accumulated other comprehensive loss(6,560)(431)(428)(416)
Accumulated deficit(314,566)(234,499)(179,584)(99,649)
Total stockholders' equity:482,438287,370183,003143,275
TOTAL LIABILITIES AND EQUITY:547,945342,206219,822171,906

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues180,290111,53513,820707
Cost of revenue
(Cost of Goods and Services Sold)
(64,572)(44,444)(6,490)(356)
Gross profit:115,71867,0917,330351
Operating expenses(187,526)(120,851)(87,929)(32,488)
Operating loss:(71,808)(53,760)(80,599)(32,137)
Nonoperating income (expense)(7,477)(1,154)665(345)
Investment income, nonoperating407612,974998
Other nonoperating expense(7,426)(1,874)(2,309)(1,343)
Interest and debt expense (774)(873)(338)
Loss from continuing operations before equity method investments, income taxes:(79,285)(55,688)(80,807)(32,820)
Other undisclosed income from continuing operations before income taxes 774873338
Loss from continuing operations before income taxes:(79,285)(54,914)(79,934)(32,482)
Income tax expense(782)(1)(1)(1)
Net loss available to common stockholders, diluted:(80,067)(54,915)(79,935)(32,483)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(80,067)(54,915)(79,935)(32,483)
Comprehensive loss:(80,067)(54,915)(79,935)(32,483)
Other undisclosed comprehensive loss, net of tax, attributable to parent(6,129)(3)(12)(14)
Comprehensive loss, net of tax, attributable to parent:(86,196)(54,918)(79,947)(32,497)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: